S&P 500   4,290.87 (-1.07%)
DOW   33,712.87 (-0.86%)
QQQ   355.81 (-1.06%)
AAPL   173.33 (-1.56%)
MSFT   312.70 (-1.52%)
META   298.38 (-0.81%)
GOOGL   128.40 (-2.07%)
AMZN   127.65 (-2.76%)
TSLA   246.03 (-0.39%)
NVDA   423.13 (+0.22%)
NIO   8.46 (+1.32%)
BABA   86.22 (-1.15%)
AMD   96.20 (-1.21%)
T   15.04 (-0.13%)
F   12.54 (-0.32%)
MU   68.45 (-0.19%)
CGC   0.94 (-0.84%)
GE   110.59 (-1.01%)
DIS   80.36 (-0.80%)
AMC   7.96 (-2.21%)
PFE   32.83 (-0.45%)
PYPL   59.06 (+0.34%)
NFLX   380.88 (-1.02%)
S&P 500   4,290.87 (-1.07%)
DOW   33,712.87 (-0.86%)
QQQ   355.81 (-1.06%)
AAPL   173.33 (-1.56%)
MSFT   312.70 (-1.52%)
META   298.38 (-0.81%)
GOOGL   128.40 (-2.07%)
AMZN   127.65 (-2.76%)
TSLA   246.03 (-0.39%)
NVDA   423.13 (+0.22%)
NIO   8.46 (+1.32%)
BABA   86.22 (-1.15%)
AMD   96.20 (-1.21%)
T   15.04 (-0.13%)
F   12.54 (-0.32%)
MU   68.45 (-0.19%)
CGC   0.94 (-0.84%)
GE   110.59 (-1.01%)
DIS   80.36 (-0.80%)
AMC   7.96 (-2.21%)
PFE   32.83 (-0.45%)
PYPL   59.06 (+0.34%)
NFLX   380.88 (-1.02%)
S&P 500   4,290.87 (-1.07%)
DOW   33,712.87 (-0.86%)
QQQ   355.81 (-1.06%)
AAPL   173.33 (-1.56%)
MSFT   312.70 (-1.52%)
META   298.38 (-0.81%)
GOOGL   128.40 (-2.07%)
AMZN   127.65 (-2.76%)
TSLA   246.03 (-0.39%)
NVDA   423.13 (+0.22%)
NIO   8.46 (+1.32%)
BABA   86.22 (-1.15%)
AMD   96.20 (-1.21%)
T   15.04 (-0.13%)
F   12.54 (-0.32%)
MU   68.45 (-0.19%)
CGC   0.94 (-0.84%)
GE   110.59 (-1.01%)
DIS   80.36 (-0.80%)
AMC   7.96 (-2.21%)
PFE   32.83 (-0.45%)
PYPL   59.06 (+0.34%)
NFLX   380.88 (-1.02%)
S&P 500   4,290.87 (-1.07%)
DOW   33,712.87 (-0.86%)
QQQ   355.81 (-1.06%)
AAPL   173.33 (-1.56%)
MSFT   312.70 (-1.52%)
META   298.38 (-0.81%)
GOOGL   128.40 (-2.07%)
AMZN   127.65 (-2.76%)
TSLA   246.03 (-0.39%)
NVDA   423.13 (+0.22%)
NIO   8.46 (+1.32%)
BABA   86.22 (-1.15%)
AMD   96.20 (-1.21%)
T   15.04 (-0.13%)
F   12.54 (-0.32%)
MU   68.45 (-0.19%)
CGC   0.94 (-0.84%)
GE   110.59 (-1.01%)
DIS   80.36 (-0.80%)
AMC   7.96 (-2.21%)
PFE   32.83 (-0.45%)
PYPL   59.06 (+0.34%)
NFLX   380.88 (-1.02%)
Positive News SentimentPositive News
NYSE:PBH

Prestige Consumer Healthcare (PBH) Stock Forecast, Price & News

$58.96
+0.58 (+0.99%)
(As of 01:06 PM ET)
Compare
Today's Range
$58.16
▼
$58.99
50-Day Range
$56.66
▼
$68.31
52-Week Range
$48.51
▼
$68.54
Volume
59,551 shs
Average Volume
246,211 shs
Market Capitalization
$2.92 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$82.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Prestige Consumer Healthcare MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
39.1% Upside
$82.00 Price Target
Short Interest
Bearish
3.02% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.35
Upright™ Environmental Score
News Sentiment
1.78mentions of Prestige Consumer Healthcare in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$2.30 M Sold Last Quarter
Proj. Earnings Growth
6.73%
From $4.31 to $4.60 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.25 out of 5 stars

Medical Sector

369th out of 961 stocks

Pharmaceutical Preparations Industry

159th out of 454 stocks

See Top Rated MarketRank™ Stocks Here

PBH stock logo

About Prestige Consumer Healthcare (NYSE:PBH) Stock

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

PBH Price History

PBH Stock News Headlines

September 22, 2023 | finance.yahoo.com
Why Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term
September 18, 2023 | markets.businessinsider.com
Canaccord Genuity Sticks to Its Buy Rating for Prestige Consumer Healthcare (PBH)
September 26, 2023 | Micro-Cap Stock Trader (Ad)
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
September 18, 2023 | americanbankingnews.com
Prestige Consumer Healthcare Inc. (NYSE:PBH) SVP Sells $149,656.80 in Stock
September 16, 2023 | americanbankingnews.com
Prestige Consumer Healthcare (NYSE:PBH) vs. Acer Therapeutics (NASDAQ:ACER) Head-To-Head Review
September 11, 2023 | msn.com
Why Prestige Consumer Healthcare (PBH) is a Top Growth Stock for the Long-Term
September 6, 2023 | finance.yahoo.com
Down -11.27% in 4 Weeks, Here's Why You Should You Buy the Dip in Prestige Consumer Healthcare (PBH)
September 5, 2023 | finance.yahoo.com
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
September 26, 2023 | Micro-Cap Stock Trader (Ad)
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
September 5, 2023 | finance.yahoo.com
Prestige Consumer (PBH) Looks Well-Placed on Brand Strength
August 29, 2023 | msn.com
PBH vs. BSX: Which Stock Should Value Investors Buy Now?
August 16, 2023 | finance.yahoo.com
Looking for a Growth Stock? 3 Reasons Why Prestige Brands (PBH) is a Solid Choice
August 14, 2023 | seekingalpha.com
Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation
August 5, 2023 | seekingalpha.com
Prestige Consumer Healthcare Inc. 2024 Q1 - Results - Earnings Call Presentation
August 4, 2023 | uk.finance.yahoo.com
Prestige Brands Holdings, Inc. (PBH)
August 3, 2023 | finance.yahoo.com
Prestige Brands (PBH) Reports Q1 Earnings: What Key Metrics Have to Say
August 3, 2023 | finance.yahoo.com
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results
July 31, 2023 | finance.yahoo.com
Factors to Note Ahead of Prestige Consumer's (PBH) Q1 Earnings
July 11, 2023 | finance.yahoo.com
Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results
July 6, 2023 | finance.yahoo.com
Prestige Consumer Healthcare Publishes Inaugural Sustainability Report
June 1, 2023 | finance.yahoo.com
Prestige Consumer Healthcare (NYSE:PBH) shareholders are still up 62% over 5 years despite pulling back 3.5% in the past week
May 31, 2023 | finance.yahoo.com
Goody’s® Introduces New “GET TO GOOD™” Marketing Campaign
May 23, 2023 | finance.yahoo.com
Dramamine® Eases Americans’ Travel Woes with ‘Ditch the Drama’ Sweepstakes Offering a Vacation to Anywhere in the World
May 9, 2023 | msn.com
DA Davidson Reiterates Prestige Consumer Healthcare (PBH) Neutral Recommendation
May 5, 2023 | finance.yahoo.com
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 42% Below Their Intrinsic Value Estimate
May 4, 2023 | msn.com
Prestige Consumer (PBH) Q4 Earnings Top Estimates, Revenues Up
May 4, 2023 | finance.yahoo.com
Prestige Brands (PBH) Beats Q4 Earnings and Revenue Estimates
See More Headlines
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Company Calendar

Last Earnings
8/03/2023
Today
9/26/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
3/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
Sector
Medical
Current Symbol
NYSE:PBH
CUSIP
74112D10
CIK
1295947
Web
www.prestigebrands.com
Phone
(914) 524-6800
Fax
302-674-5266
Employees
560
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$82.00
High Stock Price Forecast
$104.00
Low Stock Price Forecast
$71.00
Forecasted Upside/Downside
+39.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.71)
Trailing P/E Ratio
N/A
Forward P/E Ratio
13.68
P/E Growth
1.68
Net Income
$-82,310,000.00
Net Margins
-7.46%
Pretax Margin
-8.50%
Return on Equity
13.47%
Return on Assets
5.95%

Debt

Debt-to-Equity Ratio
0.89
Current Ratio
2.66
Quick Ratio
1.51

Sales & Book Value

Annual Sales
$1.13 billion
Price / Sales
2.59
Cash Flow
$5.10 per share
Price / Cash Flow
11.56
Book Value
$29.12 per share
Price / Book
2.02

Miscellaneous

Outstanding Shares
49,540,000
Free Float
48,746,000
Market Cap
$2.92 billion
Optionable
Optionable
Beta
0.59
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover
10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Ronald M. LombardiMr. Ronald M. Lombardi (Age 59)
    Chairman, Pres & CEO
    Comp: $1.98M
  • Ms. Christine Sacco (Age 47)
    Chief Financial Officer
    Comp: $958.91k
  • Mr. Jeffrey Zerillo (Age 62)
    Sr. VP of Operations
    Comp: $496.91k
  • Mr. William C. P'Pool (Age 58)
    Sr. VP, Gen. Counsel & Corp. Sec.
    Comp: $769.98k
  • Mr. Adel Mekhail (Age 62)
    Exec. VP of Marketing & Sales
    Comp: $797.94k
  • Mr. Philip David Terpolilli
    Director of Investor Relations
  • Dean Siegal
    Director of Communications
  • Ms. Mary Beth Fritz
    Sr. VP of Quality & Regulatory Affairs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













PBH Stock - Frequently Asked Questions

Should I buy or sell Prestige Consumer Healthcare stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" PBH shares.
View PBH analyst ratings or view top-rated stocks.

What is Prestige Consumer Healthcare's stock price forecast for 2023?

3 Wall Street research analysts have issued 1 year target prices for Prestige Consumer Healthcare's stock. Their PBH share price forecasts range from $71.00 to $104.00. On average, they anticipate the company's stock price to reach $82.00 in the next year. This suggests a possible upside of 39.1% from the stock's current price.
View analysts price targets for PBH or view top-rated stocks among Wall Street analysts.

How have PBH shares performed in 2023?

Prestige Consumer Healthcare's stock was trading at $62.60 at the beginning of 2023. Since then, PBH stock has decreased by 5.8% and is now trading at $58.96.
View the best growth stocks for 2023 here.

When is Prestige Consumer Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our PBH earnings forecast.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc. (NYSE:PBH) issued its earnings results on Thursday, August, 3rd. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.05. The business had revenue of $279.31 million for the quarter, compared to the consensus estimate of $278.79 million. Prestige Consumer Healthcare had a positive trailing twelve-month return on equity of 13.47% and a negative net margin of 7.46%. Prestige Consumer Healthcare's quarterly revenue was up .8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.09 earnings per share.

What ETFs hold Prestige Consumer Healthcare's stock?

ETFs with the largest weight of Prestige Consumer Healthcare (NYSE:PBH) stock in their portfolio include Invesco Pharmaceuticals ETF (PJP), Invesco S&P SmallCap Health Care ETF (PSCH), Schwab Ariel ESG ETF (SAEF), Global X Health & Wellness ETF (BFIT), SPDR S&P Pharmaceuticals ETF (XPH), ETC 6 Meridian Small Cap Equity ETF (SIXS), iShares U.S. Pharmaceuticals ETF (IHE) and Invesco S&P SmallCap Momentum ETF (XSMO).

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare issued an update on its FY 2024 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of $4.27-$4.32 for the period, compared to the consensus EPS estimate of $3.92. The company issued revenue guidance of $1.14 billion-$1.14 billion, compared to the consensus revenue estimate of $1.03 billion.

What is Ronald M. Lombardi's approval rating as Prestige Consumer Healthcare's CEO?

8 employees have rated Prestige Consumer Healthcare Chief Executive Officer Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among the company's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE), Wells Fargo & Company (WFC), International Business Machines (IBM), Micron Technology (MU) and Teva Pharmaceutical Industries (TEVA).

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (18.20%), Dimensional Fund Advisors LP (7.37%), State Street Corp (3.78%), Westwood Holdings Group Inc. (2.56%), Geode Capital Management LLC (2.13%) and Ariel Investments LLC (1.87%). Insiders that own company stock include Mary Beth Fritz and Ronald M Lombardi.
View institutional ownership trends.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $58.96.

How much money does Prestige Consumer Healthcare make?

Prestige Consumer Healthcare (NYSE:PBH) has a market capitalization of $2.92 billion and generates $1.13 billion in revenue each year. The company earns $-82,310,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis.

How many employees does Prestige Consumer Healthcare have?

The company employs 560 workers across the globe.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The official website for the company is www.prestigebrands.com. The company can be reached via phone at (914) 524-6800, via email at irinquiries@prestigebrands.com, or via fax at 302-674-5266.

This page (NYSE:PBH) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -